DNA vaccination has proven to be effective against a number of tumours and
microbial diseases. As DNA vaccines are unable to replicate, plasmid copy n
umber per cell is dependent on in vivo transfection efficiency, which is us
ually quite low. Consequently, immune responses generated are likely to be
sub-optimal due to low antigen expression levels in transfected cells. Duri
ng this study, replicating: DNA vaccines delivered intra-epidermally by gen
e gun, were assessed for their ability to more efficiently generate immune
responses in mice. The data demonstrate that, using a polyoma virus-based s
ystem of replication, 10-fold less DNA expressing the haemagglutinin gene o
f influenza virus, was required to stimulate a humoral immune response, com
pared to an equivalent non-replicating vaccine. This observation suggests t
hat the use of replicating DNA vaccines in some delivery systems may enhanc
e the effectiveness of immune responses. (C) 2000 Elsevier Science Ltd. All
rights reserved.